Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence
Background: Percutaneous transhepatic cholangioscopy (PTCS) has a major role in the treatment of hepatolithiasis. The aims of this study were to evaluate immediate and long-term results of PTCS treatment and to elucidate the risk factors for recurrence of stones or cholangitis. Methods: A retrospect...
Gespeichert in:
| Veröffentlicht in: | Gastrointestinal endoscopy 2001-03, Vol.53 (3), p.318-323 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 323 |
|---|---|
| container_issue | 3 |
| container_start_page | 318 |
| container_title | Gastrointestinal endoscopy |
| container_volume | 53 |
| creator | Lee, Sung-Koo Seo, Dong-Wan Myung, Seung-Jae Park, Eun-Taek Lim, Byeong-Cheol Kim, Hong-Ja Yoo, Kyo-Sang Park, Hyun-Ju Joo, Yeon-Ho Kim, Myung-Hwan Min, Young-Il |
| description | Background: Percutaneous transhepatic cholangioscopy (PTCS) has a major role in the treatment of hepatolithiasis. The aims of this study were to evaluate immediate and long-term results of PTCS treatment and to elucidate the risk factors for recurrence of stones or cholangitis.
Methods: A retrospective study was conducted of patients with hepatolithiasis who underwent PTCS treatment. A total of 92 patients underwent PTCS treatment and 68 were followed for 24 to 60 months (median 42 months).
Results: Complete clearance of stones was achieved in 74 (80%) patients. The rate of complete clearance was significantly lower in patients with severe intrahepatic strictures compared with that for those with no strictures (14 of 24, 58% vs. 16 of 16, 100%,
p < 0.01) and those with mild to moderate strictures (14 of 24, 58% vs. 44 of 52, 85%,
p < 0.05). Patients with severe intrahepatic strictures had a higher recurrence rate than those with no or mild strictures (100% vs. 28%,
p < 0.01). In addition the recurrence rate in patients with advanced biliary cirrhosis (Child's class B or C) was higher than in those with no or mild (Child's class A) cirrhosis (89% vs. 29%,
p < 0.01). In patients with type I and II hepatolithiasis (Tsunoda classification), stones recurred in 2 (12%) patients at 28 and 32 months after successful stone removal, without further recurrence afterwards. The recurrence rate in patients with type III and IV hepatolithiasis increased gradually up to 50% at 60 months of follow-up.
Conclusions: Severe intrahepatic stricture was the only factor that affected the immediate success rate of PTCS in the treatment of hepatolithiasis. Several risk factors including severe biliary stricture, advanced biliary cirrhosis and Tsunoda type III and IV affected the long-term results. (Gastrointest Endosc 2001;53:318-23.) |
| doi_str_mv | 10.1016/S0016-5107(01)70405-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76976044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016510701704051</els_id><sourcerecordid>76976044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-15ff1841567f0b626c3da293b366f75589a1f5921fcd35212ad40366c90ed10a3</originalsourceid><addsrcrecordid>eNqFkduKFDEQhoMo7rj6CEpAEL1orepDMu2NLIsnWFBQr0MmXdmJdndmU-kFn8GXNnNgvfQmRchXVeH7hXiK8BoB1ZtvUM6qQ9AvAV9paKGr8J5YIfS6Ulr398XqDjkTj5h_AsC6bvChOEMstelhJf58peSWbGeKC8uc7Mxb2tkcnHTbONr5OkR2cVfuOZHNE81Z-pjkgYpjyNtgOfBbeTFLurXjUnrjLKOXY5yvq0xpkol4GTNLOw8yBf4lvXU5Jj4MSuSWlGh29Fg88HZkenKq5-LHh_ffLz9VV18-fr68uKpcoyFX2HmP6xY7pT1sVK1cM9i6bzaNUl533bq36Lu-Ru-GpquxtkML5c31QAOCbc7Fi-PcXYo3C3E2U2BH43i0YLTqtYK2LWB3BF2KzIm82aUw2fTbIJh9CuaQgtkrNoDmkILB0vfstGDZTDT86zppL8DzE2DZ2dEX7S7wHdejUrou1LsjRUXGbaBk2IW9qCEUadkMMfznI38Bwf2mRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76976044</pqid></control><display><type>article</type><title>Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lee, Sung-Koo ; Seo, Dong-Wan ; Myung, Seung-Jae ; Park, Eun-Taek ; Lim, Byeong-Cheol ; Kim, Hong-Ja ; Yoo, Kyo-Sang ; Park, Hyun-Ju ; Joo, Yeon-Ho ; Kim, Myung-Hwan ; Min, Young-Il</creator><creatorcontrib>Lee, Sung-Koo ; Seo, Dong-Wan ; Myung, Seung-Jae ; Park, Eun-Taek ; Lim, Byeong-Cheol ; Kim, Hong-Ja ; Yoo, Kyo-Sang ; Park, Hyun-Ju ; Joo, Yeon-Ho ; Kim, Myung-Hwan ; Min, Young-Il</creatorcontrib><description>Background: Percutaneous transhepatic cholangioscopy (PTCS) has a major role in the treatment of hepatolithiasis. The aims of this study were to evaluate immediate and long-term results of PTCS treatment and to elucidate the risk factors for recurrence of stones or cholangitis.
Methods: A retrospective study was conducted of patients with hepatolithiasis who underwent PTCS treatment. A total of 92 patients underwent PTCS treatment and 68 were followed for 24 to 60 months (median 42 months).
Results: Complete clearance of stones was achieved in 74 (80%) patients. The rate of complete clearance was significantly lower in patients with severe intrahepatic strictures compared with that for those with no strictures (14 of 24, 58% vs. 16 of 16, 100%,
p < 0.01) and those with mild to moderate strictures (14 of 24, 58% vs. 44 of 52, 85%,
p < 0.05). Patients with severe intrahepatic strictures had a higher recurrence rate than those with no or mild strictures (100% vs. 28%,
p < 0.01). In addition the recurrence rate in patients with advanced biliary cirrhosis (Child's class B or C) was higher than in those with no or mild (Child's class A) cirrhosis (89% vs. 29%,
p < 0.01). In patients with type I and II hepatolithiasis (Tsunoda classification), stones recurred in 2 (12%) patients at 28 and 32 months after successful stone removal, without further recurrence afterwards. The recurrence rate in patients with type III and IV hepatolithiasis increased gradually up to 50% at 60 months of follow-up.
Conclusions: Severe intrahepatic stricture was the only factor that affected the immediate success rate of PTCS in the treatment of hepatolithiasis. Several risk factors including severe biliary stricture, advanced biliary cirrhosis and Tsunoda type III and IV affected the long-term results. (Gastrointest Endosc 2001;53:318-23.)</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/S0016-5107(01)70405-1</identifier><identifier>PMID: 11231390</identifier><identifier>CODEN: GAENBQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cholangiopancreatography, Endoscopic Retrograde - methods ; Cholelithiasis - diagnosis ; Cholelithiasis - mortality ; Cholelithiasis - therapy ; Endoscopy, Digestive System - methods ; Female ; Follow-Up Studies ; Humans ; Liver, biliary tract, pancreas, portal circulation, spleen ; Male ; Medical sciences ; Middle Aged ; Probability ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival Rate ; Treatment Outcome ; Tropical medicine</subject><ispartof>Gastrointestinal endoscopy, 2001-03, Vol.53 (3), p.318-323</ispartof><rights>2001 American Society for Gastrointestinal Endoscopy</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-15ff1841567f0b626c3da293b366f75589a1f5921fcd35212ad40366c90ed10a3</citedby><cites>FETCH-LOGICAL-c370t-15ff1841567f0b626c3da293b366f75589a1f5921fcd35212ad40366c90ed10a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0016-5107(01)70405-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=916672$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11231390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Sung-Koo</creatorcontrib><creatorcontrib>Seo, Dong-Wan</creatorcontrib><creatorcontrib>Myung, Seung-Jae</creatorcontrib><creatorcontrib>Park, Eun-Taek</creatorcontrib><creatorcontrib>Lim, Byeong-Cheol</creatorcontrib><creatorcontrib>Kim, Hong-Ja</creatorcontrib><creatorcontrib>Yoo, Kyo-Sang</creatorcontrib><creatorcontrib>Park, Hyun-Ju</creatorcontrib><creatorcontrib>Joo, Yeon-Ho</creatorcontrib><creatorcontrib>Kim, Myung-Hwan</creatorcontrib><creatorcontrib>Min, Young-Il</creatorcontrib><title>Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Background: Percutaneous transhepatic cholangioscopy (PTCS) has a major role in the treatment of hepatolithiasis. The aims of this study were to evaluate immediate and long-term results of PTCS treatment and to elucidate the risk factors for recurrence of stones or cholangitis.
Methods: A retrospective study was conducted of patients with hepatolithiasis who underwent PTCS treatment. A total of 92 patients underwent PTCS treatment and 68 were followed for 24 to 60 months (median 42 months).
Results: Complete clearance of stones was achieved in 74 (80%) patients. The rate of complete clearance was significantly lower in patients with severe intrahepatic strictures compared with that for those with no strictures (14 of 24, 58% vs. 16 of 16, 100%,
p < 0.01) and those with mild to moderate strictures (14 of 24, 58% vs. 44 of 52, 85%,
p < 0.05). Patients with severe intrahepatic strictures had a higher recurrence rate than those with no or mild strictures (100% vs. 28%,
p < 0.01). In addition the recurrence rate in patients with advanced biliary cirrhosis (Child's class B or C) was higher than in those with no or mild (Child's class A) cirrhosis (89% vs. 29%,
p < 0.01). In patients with type I and II hepatolithiasis (Tsunoda classification), stones recurred in 2 (12%) patients at 28 and 32 months after successful stone removal, without further recurrence afterwards. The recurrence rate in patients with type III and IV hepatolithiasis increased gradually up to 50% at 60 months of follow-up.
Conclusions: Severe intrahepatic stricture was the only factor that affected the immediate success rate of PTCS in the treatment of hepatolithiasis. Several risk factors including severe biliary stricture, advanced biliary cirrhosis and Tsunoda type III and IV affected the long-term results. (Gastrointest Endosc 2001;53:318-23.)</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cholangiopancreatography, Endoscopic Retrograde - methods</subject><subject>Cholelithiasis - diagnosis</subject><subject>Cholelithiasis - mortality</subject><subject>Cholelithiasis - therapy</subject><subject>Endoscopy, Digestive System - methods</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Probability</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tropical medicine</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkduKFDEQhoMo7rj6CEpAEL1orepDMu2NLIsnWFBQr0MmXdmJdndmU-kFn8GXNnNgvfQmRchXVeH7hXiK8BoB1ZtvUM6qQ9AvAV9paKGr8J5YIfS6Ulr398XqDjkTj5h_AsC6bvChOEMstelhJf58peSWbGeKC8uc7Mxb2tkcnHTbONr5OkR2cVfuOZHNE81Z-pjkgYpjyNtgOfBbeTFLurXjUnrjLKOXY5yvq0xpkol4GTNLOw8yBf4lvXU5Jj4MSuSWlGh29Fg88HZkenKq5-LHh_ffLz9VV18-fr68uKpcoyFX2HmP6xY7pT1sVK1cM9i6bzaNUl533bq36Lu-Ru-GpquxtkML5c31QAOCbc7Fi-PcXYo3C3E2U2BH43i0YLTqtYK2LWB3BF2KzIm82aUw2fTbIJh9CuaQgtkrNoDmkILB0vfstGDZTDT86zppL8DzE2DZ2dEX7S7wHdejUrou1LsjRUXGbaBk2IW9qCEUadkMMfznI38Bwf2mRw</recordid><startdate>200103</startdate><enddate>200103</enddate><creator>Lee, Sung-Koo</creator><creator>Seo, Dong-Wan</creator><creator>Myung, Seung-Jae</creator><creator>Park, Eun-Taek</creator><creator>Lim, Byeong-Cheol</creator><creator>Kim, Hong-Ja</creator><creator>Yoo, Kyo-Sang</creator><creator>Park, Hyun-Ju</creator><creator>Joo, Yeon-Ho</creator><creator>Kim, Myung-Hwan</creator><creator>Min, Young-Il</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200103</creationdate><title>Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence</title><author>Lee, Sung-Koo ; Seo, Dong-Wan ; Myung, Seung-Jae ; Park, Eun-Taek ; Lim, Byeong-Cheol ; Kim, Hong-Ja ; Yoo, Kyo-Sang ; Park, Hyun-Ju ; Joo, Yeon-Ho ; Kim, Myung-Hwan ; Min, Young-Il</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-15ff1841567f0b626c3da293b366f75589a1f5921fcd35212ad40366c90ed10a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cholangiopancreatography, Endoscopic Retrograde - methods</topic><topic>Cholelithiasis - diagnosis</topic><topic>Cholelithiasis - mortality</topic><topic>Cholelithiasis - therapy</topic><topic>Endoscopy, Digestive System - methods</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Probability</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Sung-Koo</creatorcontrib><creatorcontrib>Seo, Dong-Wan</creatorcontrib><creatorcontrib>Myung, Seung-Jae</creatorcontrib><creatorcontrib>Park, Eun-Taek</creatorcontrib><creatorcontrib>Lim, Byeong-Cheol</creatorcontrib><creatorcontrib>Kim, Hong-Ja</creatorcontrib><creatorcontrib>Yoo, Kyo-Sang</creatorcontrib><creatorcontrib>Park, Hyun-Ju</creatorcontrib><creatorcontrib>Joo, Yeon-Ho</creatorcontrib><creatorcontrib>Kim, Myung-Hwan</creatorcontrib><creatorcontrib>Min, Young-Il</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Sung-Koo</au><au>Seo, Dong-Wan</au><au>Myung, Seung-Jae</au><au>Park, Eun-Taek</au><au>Lim, Byeong-Cheol</au><au>Kim, Hong-Ja</au><au>Yoo, Kyo-Sang</au><au>Park, Hyun-Ju</au><au>Joo, Yeon-Ho</au><au>Kim, Myung-Hwan</au><au>Min, Young-Il</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2001-03</date><risdate>2001</risdate><volume>53</volume><issue>3</issue><spage>318</spage><epage>323</epage><pages>318-323</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><coden>GAENBQ</coden><abstract>Background: Percutaneous transhepatic cholangioscopy (PTCS) has a major role in the treatment of hepatolithiasis. The aims of this study were to evaluate immediate and long-term results of PTCS treatment and to elucidate the risk factors for recurrence of stones or cholangitis.
Methods: A retrospective study was conducted of patients with hepatolithiasis who underwent PTCS treatment. A total of 92 patients underwent PTCS treatment and 68 were followed for 24 to 60 months (median 42 months).
Results: Complete clearance of stones was achieved in 74 (80%) patients. The rate of complete clearance was significantly lower in patients with severe intrahepatic strictures compared with that for those with no strictures (14 of 24, 58% vs. 16 of 16, 100%,
p < 0.01) and those with mild to moderate strictures (14 of 24, 58% vs. 44 of 52, 85%,
p < 0.05). Patients with severe intrahepatic strictures had a higher recurrence rate than those with no or mild strictures (100% vs. 28%,
p < 0.01). In addition the recurrence rate in patients with advanced biliary cirrhosis (Child's class B or C) was higher than in those with no or mild (Child's class A) cirrhosis (89% vs. 29%,
p < 0.01). In patients with type I and II hepatolithiasis (Tsunoda classification), stones recurred in 2 (12%) patients at 28 and 32 months after successful stone removal, without further recurrence afterwards. The recurrence rate in patients with type III and IV hepatolithiasis increased gradually up to 50% at 60 months of follow-up.
Conclusions: Severe intrahepatic stricture was the only factor that affected the immediate success rate of PTCS in the treatment of hepatolithiasis. Several risk factors including severe biliary stricture, advanced biliary cirrhosis and Tsunoda type III and IV affected the long-term results. (Gastrointest Endosc 2001;53:318-23.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>11231390</pmid><doi>10.1016/S0016-5107(01)70405-1</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0016-5107 |
| ispartof | Gastrointestinal endoscopy, 2001-03, Vol.53 (3), p.318-323 |
| issn | 0016-5107 1097-6779 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76976044 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Cholangiopancreatography, Endoscopic Retrograde - methods Cholelithiasis - diagnosis Cholelithiasis - mortality Cholelithiasis - therapy Endoscopy, Digestive System - methods Female Follow-Up Studies Humans Liver, biliary tract, pancreas, portal circulation, spleen Male Medical sciences Middle Aged Probability Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Survival Rate Treatment Outcome Tropical medicine |
| title | Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: An evaluation of long-term results and risk factors for recurrence |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T03%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20transhepatic%20cholangioscopic%20treatment%20for%20hepatolithiasis:%20An%20evaluation%20of%20long-term%20results%20and%20risk%20factors%20for%20recurrence&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Lee,%20Sung-Koo&rft.date=2001-03&rft.volume=53&rft.issue=3&rft.spage=318&rft.epage=323&rft.pages=318-323&rft.issn=0016-5107&rft.eissn=1097-6779&rft.coden=GAENBQ&rft_id=info:doi/10.1016/S0016-5107(01)70405-1&rft_dat=%3Cproquest_cross%3E76976044%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76976044&rft_id=info:pmid/11231390&rft_els_id=S0016510701704051&rfr_iscdi=true |